So far, the magnate’s predictions have been correct, so his statement would mean that we will soon be able to see the light at the end of the tunnel.
3 min read
Despite the increase in cases and deaths from COVID-19, vaccines developed over the past few months have performed well when tested. Thanks to this, its spread and application has started in some countries such as England and Russia, which gives hope to the world’s people that the pandemic may end.
In addition, there is the latest statement by Bill Gates in this regard. And according to the American businessman, the health emergency could end in the spring of next year 2021:
“By spring the numbers will change drastically and it will be possible to return to normal,” commented the mogul during an interview for NBC. He also thanked people for realizing the importance of using the mask and other necessary measures to reduce the number of infections.
However, he added that “the next four or five months will be pretty bleak”. This is due to the winter season. In addition, he warned that the return to normal will be drastic, although the situation could be different by next spring. In fact, he estimates the world can be restored by the end of 2021.
It is worth noting that so far the predictions of Bill Gates were accurate. In 2015, it even warned of the possible arrival of a virus that would spread rapidly in the air and through contact with asymptomatically infected people (something very similar to that with the coronavirus).
Another prediction to highlight is that Microsoft’s founder predicted in mid-September that the Pfizer vaccine would be the first to become available. Even during an interview with CNBC, Bill Gates commented:
“I think once we’re in December or January, there will likely be at least two or three of them going to get approval when they’re in effect. We have phase 3 trials underway. The only vaccine that, if all goes well, could apply for an emergency license in late October would be Pfizer. ”
However, the American philanthropist did not release any other vaccines. Indeed, he noted that AstraZeneca and Oxford Pfizer would follow in a second phase.